| abstract |
The present invention provides an antidiarrheal agent that effectively stops or significantly reduces bowel movements and fluid loss in patients who are under treatment to eliminate the cause of diarrhea or who do not have a cause of diarrhea. A kit comprising an H1 receptor antagonist and an H2 receptor antagonist, wherein the H1 receptor antagonist comprises cetirizine, levocetirizine, or a mixture thereof, and the H2 receptor antagonist comprises famotidine, ranitidine, or A kit comprising a mixture of these. [Selection] Figure 1 |